Internal Medicine

3151 questions

Question 1201Question →

A 74-year-old woman is evaluated in the emergency department for the sudden onset of extensive ecchymoses over her trunk and a large, expanding hematoma on her right thigh. She has no prior personal or family history of bleeding disorders. Her past medical history is significant for rheumatoid arthritis. Vital signs are within normal limits. Laboratory studies reveal a hemoglobin of 9.4 g/dL, platelet count of 250,000/mm³, prothrombin time (PT) of 12.5 seconds (normal: 11-15 sec), and activated partial thromboplastin time (aPTT) of 78 seconds (normal: 25-35 sec). Thrombin time is normal.

Arrange the following diagnostic steps in the correct chronological sequence required to definitively diagnose and fully characterize this patient's underlying hemostatic disorder.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Immediate 1:1 mixing study -> Incubated 1:1 mixing study -> Specific intrinsic pathway factor activity levels -> Bethesda assay.
The evaluation of an isolated prolonged aPTT in a patient with acute, severe bleeding requires a systematic approach. The first step is an immediate 1:1 mixing study to broadly differentiate factor deficiencies from inhibitors. Because acquired Factor VIII autoantibodies are uniquely time- and temperature-dependent, the immediate mix may falsely correct; therefore, an incubated mixing study at 37°C for 1 to 2 hours is the mandatory next step to unmask the inhibitor. Once the inhibitor pattern (failure to correct after incubation) is established, specific intrinsic factor activity levels (VIII, IX, XI) are measured to identify the exact target, which will show a markedly reduced Factor VIII level. Finally, a Bethesda assay is performed to quantify the exact titer of the Factor VIII inhibitor, which is essential for determining whether to treat the acute bleeding with high-dose Factor VIII or bypassing agents like recombinant Factor VIIa.

Step-by-Step Solution

1
Recognize the clinical presentation of acquired hemophilia A.
The patient is an older adult with an autoimmune disease (rheumatoid arthritis) presenting with severe spontaneous bleeding and an isolated prolonged aPTT, highly suspicious for an acquired Factor VIII inhibitor.
Identifying the likely diagnosis guides the specific sequential laboratory workup for coagulation inhibitors.
2
Determine the first laboratory step to evaluate an isolated prolonged aPTT.
An immediate 1:1 mixing study with normal plasma is performed.
This differentiates a factor deficiency (aPTT corrects to normal) from an inhibitor (aPTT remains prolonged). However, acquired FVIII inhibitors often show immediate correction.
3
Address the time-dependent nature of Factor VIII inhibitors.
An incubated 1:1 mixing study at 37°C for 1-2 hours must follow.
Factor VIII autoantibodies are time- and temperature-dependent. The aPTT will prolong only after incubation, confirming the presence of this specific type of inhibitor.
4
Identify the specific target of the inhibitor.
Specific intrinsic pathway coagulation factor activity levels (VIII, IX, XI) are measured.
Once an inhibitor pattern is confirmed, measuring individual factor levels identifies which specific factor is being neutralized (Factor VIII will be selectively low).
5
Quantify the inhibitor to guide management.
A Bethesda assay is performed as the final diagnostic step.
The Bethesda assay quantifies the strength (titer) of the Factor VIII inhibitor. High titers require bypassing agents like recombinant Factor VIIa, whereas low titers may respond to high-dose Factor VIII concentrates.

Key Concept

The sequential diagnostic algorithm for acquired hemophilia A (Factor VIII inhibitor) requires an immediate mixing study, followed by an incubated mixing study to detect time-dependent inhibitors, specific factor assays to identify the target, and finally a Bethesda assay to quantify the inhibitor titer.
Estimated Time:1m 30s
Question 1202Question →

During morning rounds on the inpatient hematology unit, a resident assesses a 38-year-old male who was admitted four days ago with a new diagnosis of acute promyelocytic leukemia. He was immediately started on targeted induction therapy including a vitamin A derivative. Over the last 12 hours, the patient has developed a fever, progressive shortness of breath, and a weight gain of 3.5 kg3.5\text{ kg}. Temperature is 38.5∘C38.5^\circ\text{C} (101.3∘F101.3^\circ\text{F}), blood pressure is 105/65 mmHg105/65\text{ mmHg}, pulse is 118/min118/\text{min}, and respiratory rate is 26/min26/\text{min}. Pulse oximetry shows 89%89\% on ambient air. Physical examination reveals elevated jugular venous pressure and diffuse bilateral crackles on lung auscultation. Laboratory studies show a leukocyte count of 28,000/μL28,000/\mu\text{L}, which has increased from 4,500/μL4,500/\mu\text{L} on admission. A chest radiograph demonstrates bilateral interstitial opacities and a small right-sided pleural effusion. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Start therapy with high-dose corticosteroids

Answer

Start therapy with high-dose corticosteroids
This patient's presentation of fever, dyspnea, weight gain, pulmonary infiltrates, and leukocytosis shortly after starting all-trans retinoic acid (ATRA) for acute promyelocytic leukemia is highly characteristic of differentiation syndrome. The prompt initiation of high-dose corticosteroids, such as dexamethasone, is life-saving and constitutes the definitive next step in management.

Step-by-Step Solution

1
Identify the underlying diagnosis and the current treatment phase based on the clinical history.
The patient has acute promyelocytic leukemia (APL) and recently began induction therapy with a vitamin A derivative (all-trans retinoic acid).
Establishing the pharmacological context is necessary to anticipate specific drug-related complications.
2
Analyze the new onset of symptoms and laboratory findings.
The patient presents with fever, respiratory distress, weight gain, pulmonary edema, and a rising leukocyte count.
These findings precisely map to the diagnostic criteria for a specific systemic reaction.
3
Synthesize the findings to determine the correct immediate management step.
The clinical picture represents differentiation syndrome (formerly ATRA syndrome). The required intervention is immediate administration of high-dose dexamethasone.
Corticosteroids halt the severe inflammatory cytokine release causing the capillary leak and respiratory distress.

Key Concept

Differentiation syndrome is a life-threatening complication of all-trans retinoic acid therapy in acute promyelocytic leukemia. It presents with fever, respiratory distress, weight gain, and pulmonary infiltrates, and requires immediate treatment with high-dose corticosteroids.
Estimated Time:1m 15s
Question 1203Question →

A 67-year-old retired mechanic is evaluated in the emergency department for severe shortness of breath that has progressively worsened over the past 48 hours. He has a medical history of heart failure with reduced ejection fraction (ejection fraction 40%), atrial fibrillation, and severe chronic obstructive pulmonary disease (COPD) due to a 50 pack-year smoking history. Upon arrival, his temperature is 36.4∘C36.4^\circ\text{C} (97.5∘F97.5^\circ\text{F}), blood pressure is 148/86 mm Hg148/86\text{ mm Hg}, heart rate is 102/min102/\text{min}, respiratory rate is 28/min28/\text{min}, and oxygen saturation is 85%85\% on room air. The patient is lethargic but arousable and is using accessory muscles of respiration. Physical examination reveals a prolonged expiratory phase with diffuse polyphonic wheezing bilaterally. There are no crackles. The jugular venous pressure is 6 cm H2O6\text{ cm H}_2\text{O}. Cardiac examination shows an irregularly irregular rhythm without murmurs. Bilateral lower extremities have trace pitting edema that the patient states is his baseline. A portable chest radiograph shows hyperinflated lung fields and flattened diaphragms, without focal opacities or pleural effusions. Arterial blood gas analysis on room air reveals:

pHpH: 7.247.24
PaCO2PaCO_2: 68 mm Hg68\text{ mm Hg}
PaO2PaO_2: 54 mm Hg54\text{ mm Hg}
HCO3−HCO_3^-: 28 mEq/L28\text{ mEq/L}

Recent outpatient laboratories from one week ago showed a thyroid-stimulating hormone (TSH) of 1.1 μU/mL1.1\text{ }\mu\text{U/mL} (normal: 0.5-5.0) and a free T4 of 0.6 ng/dL0.6\text{ ng/dL} (normal: 0.9-1.7). Which of the following is the most appropriate initial step in the management of this patient's acute respiratory distress?

Show answer & explanation

Answer: Initiate noninvasive positive pressure ventilation and administer inhaled bronchodilators

Answer

Initiate noninvasive positive pressure ventilation and administer inhaled bronchodilators
The correct approach is to initiate noninvasive positive pressure ventilation (NIPPV) and inhaled bronchodilators. This patient is experiencing a severe COPD exacerbation complicated by acute hypercapnic respiratory failure (respiratory acidosis with pH < 7.35 and PaCO2 > 45 mm Hg). NIPPV is the evidence-based, first-line intervention to decrease the work of breathing, improve alveolar ventilation, correct the acid-base derangement, and reduce the risk of requiring invasive mechanical ventilation.

Step-by-Step Solution

1
Analyze the patient's clinical signs and imaging to identify the primary etiology of respiratory distress.
The physical examination shows diffuse wheezing, prolonged expiration, normal JVP, and no crackles. The chest X-ray shows hyperinflation without pulmonary edema. This confirms a COPD exacerbation rather than acute decompensated heart failure.
Differentiating between cardiac and pulmonary causes of dyspnea in a patient with a history of both diseases is crucial for selecting the correct therapeutic pathway.
2
Interpret the arterial blood gas (ABG) results.
The ABG demonstrates acidemia (pH 7.24) driven by hypercapnia (PaCO2 68 mm Hg) with appropriate, mild metabolic compensation (HCO3 28 mEq/L).
Identifying acute-on-chronic respiratory acidosis defines the severity of the COPD exacerbation and the need for immediate ventilatory support.
3
Determine the optimal intervention for acute hypercapnic respiratory failure in COPD.
Noninvasive positive pressure ventilation (NIPPV) is indicated because the pH is less than 7.35 and the PaCO2 is greater than 45 mm Hg.
NIPPV reduces the work of breathing, improves gas exchange, and decreases the need for endotracheal intubation in patients with severe COPD exacerbations.

Key Concept

The primary indication for noninvasive positive pressure ventilation (NIPPV) in chronic obstructive pulmonary disease (COPD) exacerbations is acute hypercapnic respiratory failure, defined by respiratory acidosis (pH < 7.35 and PaCO2 > 45 mm Hg).
Question 1204Question →

A 28-year-old man comes to the physician because of a 5-day history of right knee swelling, left heel pain, and redness in both eyes. He reports no recent trauma. Four weeks ago, he had a diarrheal illness that resolved spontaneously after 33 days. His temperature is 37.2∘C37.2^{\circ}\text{C} (99.0∘F99.0^{\circ}\text{F}), blood pressure is 122/78122/78 mmHg, and pulse is 84/min. Physical examination shows a moderately effused, warm, and tender right knee. There is marked tenderness to palpation at the insertion of the left Achilles tendon. The conjunctivae are injected bilaterally. Arthrocentesis of the right knee yields synovial fluid with a leukocyte count of 22,000/mm322,000/\text{mm}^3 (75%75\% neutrophils). Gram stain of the fluid shows no organisms, and polarized light microscopy reveals no crystals. Which of the following is the most appropriate initial pharmacotherapy for this patient's current symptoms?

Show answer & explanation

Answer: Oral indomethacin

Answer

The most appropriate initial pharmacotherapy is a nonsteroidal anti-inflammatory drug (NSAID) such as oral indomethacin.
The clinical picture of acute asymmetric oligoarthritis, enthesitis (Achilles tenderness), and conjunctivitis following a gastrointestinal infection is highly characteristic of reactive arthritis. Synovial fluid analysis typically shows an inflammatory pattern (leukocytes between 2,0002,000 and 50,000/mm350,000/\text{mm}^3) but is sterile, with no crystals or organisms. The initial management of choice for the joint inflammation in reactive arthritis is systemic nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin. These agents provide rapid relief of symptoms while the condition naturally resolves in most patients.

Step-by-Step Solution

1
Analyze the patient's history and clinical presentation.
The patient exhibits asymmetric oligoarthritis (right knee), enthesitis (left Achilles tendon), and conjunctivitis following a recent diarrheal illness.
Identifying the classic clinical triad and linking it to a preceding gastrointestinal infection establishes the clinical syndrome of reactive arthritis.
2
Evaluate the synovial fluid analysis results.
The fluid shows 22,00022,000 leukocytes/mm3\text{mm}^3 with negative Gram stain and no crystals.
This inflammatory but sterile profile confidently rules out septic arthritis (which typically has >50,000>50,000 WBCs/mm3\text{mm}^3 and positive cultures) and crystal arthropathies like gout.
3
Determine the most appropriate initial therapy for the diagnosed condition.
Systemic NSAIDs are selected as the first-line treatment.
Reactive arthritis is initially managed with symptomatic anti-inflammatory therapy to reduce joint pain and swelling.

Key Concept

Diagnosis and initial management of reactive arthritis.
Question 1205Question →

A 32-year-old man comes to the emergency department due to severe right upper quadrant abdominal pain and progressive fatigue over the past week. He also reports that his urine has occasionally appeared unusually dark, particularly in the morning. He has no significant past medical history and takes no medications. His temperature is 37.2°C (99.0°F), blood pressure is 128/82 mm Hg, and pulse is 98/min. Physical examination reveals scleral icterus, pale conjunctivae, and right upper quadrant abdominal tenderness with hepatomegaly.

Laboratory studies show:

ParameterResult
Hemoglobin8.4 g/dL
Mean corpuscular volume94 fL
Platelets92,000/mm³
Leukocytes3,500/mm³
Total bilirubin3.8 mg/dL
Indirect bilirubin3.1 mg/dL
Lactate dehydrogenase1,450 U/L
Haptoglobin< 10 mg/dL

Doppler ultrasound of the abdomen demonstrates absent blood flow in the hepatic veins.

Which of the following is the most appropriate next step to confirm the underlying cause of this patient's findings?

Show answer & explanation

Answer: Flow cytometry for CD55 and CD59

Answer

Flow cytometry for CD55 and CD59
The correct answer is flow cytometry for CD55 and CD59. This patient's presentation of intravascular hemolysis (dark urine, elevated lactate dehydrogenase, low haptoglobin), pancytopenia, and atypical venous thrombosis (Budd-Chiari syndrome) is the classic triad for Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is an acquired hematopoietic stem cell disorder caused by a PIGA gene mutation, which leads to a deficiency of glycosylphosphatidylinositol (GPI) anchor proteins. This results in the absence of complement regulatory proteins, specifically CD55 (decay-accelerating factor) and CD59 (MAC-inhibitory protein), on cell surfaces. Without these proteins, red blood cells become highly susceptible to complement-mediated destruction. Flow cytometry of peripheral blood is the gold standard diagnostic test to confirm the absence of these specific proteins on the surface of red blood cells and leukocytes.

Step-by-Step Solution

1
Analyze the patient's clinical symptoms and initial physical examination findings.
The patient has fatigue, jaundice, dark morning urine, and abdominal pain with hepatomegaly.
To establish the primary clinical problems, which suggest hemolysis (jaundice, dark urine) and a hepatic issue (RUQ pain, hepatomegaly).
2
Interpret the laboratory and imaging results.
Labs show intravascular hemolysis (high LDH, high indirect bilirubin, low haptoglobin) and pancytopenia. Ultrasound confirms Budd-Chiari syndrome (hepatic vein thrombosis).
To objectively confirm the pathophysiologic processes occurring in the patient.
3
Synthesize the findings to form a unifying diagnosis.
The triad of intravascular hemolysis, pancytopenia, and atypical venous thrombosis is highly specific for Paroxysmal Nocturnal Hemoglobinuria (PNH).
To narrow down the differential diagnosis and select the appropriate confirmatory test.
4
Identify the gold standard diagnostic test for the suspected condition.
Flow cytometry for CD55 and CD59 confirms the diagnosis of PNH.
Because PNH is caused by an absence of the GPI anchor, which normally secures CD55 and CD59 to the cell surface, detecting their absence via flow cytometry is diagnostic.

Key Concept

Diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Question 1206Question →

A 3838-year-old man is evaluated in the emergency department for progressive fatigue, severe epistaxis, and bleeding from his gums over the past two days. He has no significant past medical history and takes no medications. Vital signs are: Temperature 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), Blood pressure 100/60 mm Hg100/60 \text{ mm Hg}, Heart rate 112/min112/\text{min}, Respiratory rate 18/min18/\text{min}. Physical examination reveals marked mucosal pallor, continuous gingival oozing, and extensive coalescing petechiae and purpura over the trunk and bilateral lower extremities. Laboratory studies show:

Leukocyte count: 2,800/mm32,800/\text{mm}^3
- Neutrophils: 15%15\%
- Lymphocytes: 25%25\%
- Atypical cells: 60%60\%
Hemoglobin: 7.4 g/dL7.4 \text{ g/dL}
Platelet count: 15,000/mm315,000/\text{mm}^3
Prothrombin time: 24 seconds24 \text{ seconds}
Partial thromboplastin time: 54 seconds54 \text{ seconds}
Fibrinogen: 65 mg/dL65 \text{ mg/dL} (Normal: 150−400 mg/dL150-400 \text{ mg/dL})
D-dimer: 8,500 ng/mL8,500 \text{ ng/mL} (Normal: <500 ng/mL< 500 \text{ ng/mL})

Peripheral blood smear demonstrates predominant cells with bilobed nuclei and dense, coarse azurophilic granules. Several of these cells contain bundles of red-staining, needle-like cytoplasmic inclusions. Which of the following is the most appropriate initial step in the management of this patient?

Show answer & explanation

Answer: Administer all-trans retinoic acid

Answer

The most appropriate initial step is to administer all-trans retinoic acid (ATRA) immediately.
The patient's presentation of pancytopenia, severe coagulopathy (prolonged PT/aPTT, low fibrinogen, elevated D-dimer), and peripheral smear showing heavily granulated cells with bundles of Auer rods is highly characteristic of Acute Promyelocytic Leukemia (APL), the M3 subtype of acute myeloid leukemia. APL is driven by the t(15;17) translocation, which fuses the PML gene with the retinoic acid receptor alpha (RARA) gene, halting cellular differentiation at the promyelocyte stage. These abnormal promyelocytes contain primary granules rich in tissue factor and other procoagulants. When released, they trigger widespread Disseminated Intravascular Coagulation (DIC), making bleeding the leading cause of early mortality. The administration of all-trans retinoic acid (ATRA) overcomes this block, forcing the promyelocytes to differentiate and mature. This rapidly reverses the coagulopathy. Because of the high risk of catastrophic hemorrhage, ATRA must be started immediately based on clinical and morphological suspicion. Treatment should never be delayed pending cytogenetic or molecular confirmation.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has pancytopenia, severe bleeding, and laboratory evidence of Disseminated Intravascular Coagulation (DIC) as shown by prolonged PT/aPTT, low fibrinogen, and elevated D-dimer.
Identifying the life-threatening complication (DIC) is crucial for acute management.
2
Evaluate the peripheral blood smear description.
Atypical cells with bilobed nuclei, dense azurophilic granules, and bundles of Auer rods (faggot cells) are diagnostic for Acute Promyelocytic Leukemia (APL).
Morphology provides the immediate presumed diagnosis needed to initiate emergency targeted therapy.
3
Determine the next best step in management based on the presumed diagnosis of APL with DIC.
All-trans retinoic acid (ATRA) must be initiated immediately upon morphological suspicion.
ATRA drives the differentiation of malignant promyelocytes into mature neutrophils, halting the release of procoagulants and rapidly resolving the DIC. Waiting for cytogenetic confirmation before treatment is contraindicated.

Key Concept

Acute Promyelocytic Leukemia (APL) is a medical emergency that frequently presents with severe Disseminated Intravascular Coagulation (DIC). All-trans retinoic acid (ATRA) must be initiated immediately upon morphological suspicion to prevent fatal hemorrhage; treatment should never be delayed for cytogenetic confirmation.
Estimated Time:1m 30s
Question 1207Question →

An essential skill in hematology is interpreting coagulation panels to diagnose bleeding disorders. Match each underlying hematologic disorder with its most characteristic laboratory profile.

Click a left item, then click its matching right item

Items

Hemophilia A
von Willebrand disease
Disseminated intravascular coagulation (DIC)
Immune thrombocytopenic purpura (ITP)

Matches

Show answer & explanation

Answer

Hemophilia A matches with isolated prolonged aPTT. von Willebrand disease matches with prolonged aPTT and prolonged bleeding time. DIC matches with prolonged PT, aPTT, thrombocytopenia, and decreased fibrinogen. ITP matches with isolated thrombocytopenia.
Each bleeding disorder uniquely disrupts a specific component of the hemostatic system. ITP exclusively destroys platelets (causing isolated thrombocytopenia). Hemophilia A is an isolated Factor VIII deficiency (causing isolated prolonged aPTT). vWD impairs platelet adhesion and Factor VIII stability (causing prolonged bleeding time and aPTT). DIC indiscriminately consumes all coagulation factors and platelets (causing prolonged PT/aPTT, low platelets, and low fibrinogen).

Step-by-Step Solution

1
Evaluate the platelet count and bleeding time to assess primary hemostasis.
Defects in primary hemostasis (ITP, vWD) will show either thrombocytopenia or a prolonged bleeding time.
Primary hemostasis involves the initial formation of the platelet plug at the site of endothelial injury.
2
Evaluate the PT and aPTT to assess secondary hemostasis.
Intrinsic pathway defects (Hemophilia A) prolong aPTT. Deficiencies affecting both pathways or involving massive consumption (DIC) prolong both PT and aPTT.
Secondary hemostasis relies on the coagulation cascade to generate fibrin and stabilize the clot.
3
Combine the lab findings to establish the specific diagnosis.
vWD uniquely affects both primary (platelet adhesion) and secondary (Factor VIII half-life) hemostasis. DIC is broadly consumptive. ITP is strictly limited to platelet destruction. Hemophilia A is strictly limited to Factor VIII.
Identifying the specific combination of coagulation derangements reliably isolates the underlying pathology.

Key Concept

Interpretation of basic coagulation profiles (PT, aPTT, bleeding time, platelet count) to differentiate primary hemostasis defects, secondary hemostasis defects, and consumptive coagulopathies.
Estimated Time:1m 0s
Question 1208Question →

A 32-year-old man presents to the emergency department triage desk with a 4-week history of severe cough, low-grade fevers, and drenching night sweats. He recently returned from a prolonged trip to a region where tuberculosis is highly endemic. He is currently sitting in the crowded main waiting room. Arrange the following steps in the correct chronological order for managing this patient's suspected infection.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence prioritizes immediate infection control (isolation), followed by non-invasive anatomical diagnostic imaging (radiograph), then microbiological sampling (sputum culture), and finally the initiation of targeted pharmacotherapy.
The fundamental principle of managing a highly contagious, suspected airborne infection in an acute care setting is to secure the environment first. Therefore, airborne isolation must occur before any further diagnostic steps. Once isolated, a chest radiograph provides rapid confirmation of the suspected pathology. Following anatomical confirmation, microbiological sampling (sputum for AFB) must be completed. Finally, empiric pharmacotherapy is initiated only after diagnostic samples are secured to prevent sterilizing the cultures.

Step-by-Step Solution

1
Transfer the patient to an airborne infection isolation room.
The patient is placed in a negative-pressure environment.
Airborne isolation is the most critical first step to prevent nosocomial transmission of highly contagious airborne pathogens like Mycobacterium tuberculosis.
2
Perform a chest radiograph.
Evaluation for classic signs of tuberculosis, such as apical infiltrates or cavitary lesions.
Imaging helps solidify the pre-test probability of active pulmonary tuberculosis and guides the necessity of further intensive microbiological workup.
3
Collect sputum specimens for AFB smear and culture.
Samples are secured for organism identification and susceptibility testing.
Cultures must be drawn prior to administering antimicrobials to ensure the highest possible yield for organism growth and accurate drug resistance profiling.
4
Initiate a four-drug empiric antituberculous treatment regimen.
The patient begins active medical therapy.
Once the patient is isolated and diagnostic data is secured, treatment is initiated to treat the infection and rapidly decrease the patient's infectivity.

Key Concept

Initial management sequence for suspected active pulmonary tuberculosis
Question 1209Question →

A 64-year-old man with a 15-year history of poorly controlled type 2 diabetes mellitus is evaluated in the outpatient clinic for a chronic ulcer on the plantar surface of his right foot. He first noticed the ulcer 8 weeks ago. He has established peripheral neuropathy and reports no pain at the site. His temperature is 37.1°C (98.8°F), blood pressure is 135/82 mmHg, and pulse is 78/min. Physical examination reveals a 2.5-cm, full-thickness ulcer under the first metatarsal head. The ulcer base is composed of pale granulation tissue. There is no surrounding erythema, warmth, fluctuance, or purulent discharge. A sterile, blunt stainless-steel probe easily reaches the underlying bone. Pedal pulses are palpable bilaterally. Laboratory studies show a leukocyte count of 7,500/μL7,500/\mu L and an erythrocyte sedimentation rate of 65 mm/h65 \text{ mm/h}. A plain radiograph of the right foot demonstrates cortical erosion and periosteal elevation at the first metatarsal head. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Obtain a bone biopsy for microbiological culture prior to initiating antibiotic therapy

Answer

The most appropriate next step is to obtain a bone biopsy for microbiological culture prior to initiating antibiotic therapy.
The patient has classic findings of diabetic foot osteomyelitis (chronic ulcer, positive probe-to-bone test, elevated ESR, and typical radiographic changes). Because he is hemodynamically stable and has no evidence of an acute, severe, or spreading soft-tissue infection, there is no urgent need for empiric antibiotics. The gold standard for guiding the prolonged antibiotic course required for osteomyelitis is a bone biopsy for culture and histology. Withholding antibiotics until the biopsy is performed ensures the highest diagnostic yield, allowing for targeted, narrow-spectrum therapy in alignment with strong antimicrobial stewardship principles.

Step-by-Step Solution

1
Evaluate the clinical presentation and diagnostic findings.
The patient has a chronic diabetic foot ulcer with a positive probe-to-bone test, elevated ESR, and radiographic evidence of bone destruction, strongly confirming the diagnosis of osteomyelitis.
Establishing the diagnosis of osteomyelitis determines the need for prolonged (typically 6-week) antibiotic therapy.
2
Assess the severity of the infection and patient stability.
The patient is afebrile, hemodynamically stable, has normal leukocyte counts, and lacks signs of acute spreading soft-tissue infection (no cellulitis, fluctuance, or purulence).
Differentiating between an acute limb-threatening infection and a chronic stable infection dictates the urgency of antibiotic initiation.
3
Determine the optimal microbiological sampling method.
Since the patient is stable, empiric antibiotics should be withheld in favor of obtaining a deep bone biopsy for definitive culture and susceptibility testing.
A bone biopsy allows for targeted, narrow-spectrum antibiotic therapy, which improves cure rates and minimizes the risk of multidrug-resistant organism selection and drug toxicity.

Key Concept

In clinically stable patients with diabetic foot osteomyelitis (lacking systemic toxicity or severe local cellulitis), empiric antibiotics should be withheld until a bone biopsy is performed to allow for targeted, pathogen-specific therapy.
Question 1210Question →

Match each peripheral blood smear description or characteristic laboratory finding with the most likely underlying hematologic disorder.

Click a left item, then click its matching right item

Items

Hypersegmented neutrophils and macro-ovalocytes
Schistocytes, elevated lactate dehydrogenase, and normal PT/aPTT
Spherocytes, reticulocytosis, and a positive direct antiglobulin test
Teardrop cells (dacrocytes), nucleated red blood cells, and a left shift in granulocytes

Matches

Show answer & explanation

Answer

Hypersegmented neutrophils match with Megaloblastic anemia; Schistocytes with normal PT/aPTT match with Thrombotic thrombocytopenic purpura; Spherocytes with a positive DAT match with Autoimmune hemolytic anemia; Teardrop cells match with Primary myelofibrosis.
Each peripheral smear finding represents a distinct pathophysiologic mechanism. Megaloblastic anemia impairs DNA synthesis, causing macro-ovalocytes and hypersegmented neutrophils. TTP causes mechanical shearing of red blood cells in microthrombi, resulting in schistocytes without consuming coagulation factors. Autoimmune hemolytic anemia involves splenic macrophage removal of antibody-coated red blood cell membrane, producing spherocytes with a positive DAT. Primary myelofibrosis distorts red blood cells as they squeeze through fibrotic marrow, yielding teardrop cells.

Step-by-Step Solution

1
Analyze the first peripheral smear finding: Hypersegmented neutrophils and macro-ovalocytes.
Identified as a defect in DNA synthesis affecting all cell lines.
These specific morphological changes are highly sensitive and specific for megaloblastic hematopoiesis.
2
Analyze the second finding: Schistocytes with normal PT/aPTT.
Identified as a primary thrombotic microangiopathy.
Schistocytes indicate intravascular hemolysis from mechanical shearing. Normal coagulation distinguishes it from Disseminated Intravascular Coagulation (DIC).
3
Analyze the third finding: Spherocytes and a positive direct antiglobulin test.
Identified as an antibody-mediated hemolytic process.
The positive DAT specifically confirms the presence of antibodies or complement on the red blood cell surface, defining autoimmune hemolytic anemia.
4
Analyze the fourth finding: Teardrop cells and nucleated red blood cells.
Identified as a leukoerythroblastic picture due to bone marrow replacement.
Marrow fibrosis forces hematopoietic cells into the periphery prematurely and causes mechanical distortion (teardrop shape) of red cells as they exit.

Key Concept

Interpretation of peripheral blood smears is crucial for differentiating mechanisms of anemia and underlying hematologic disorders.
Question 1211Question →

A 54-year-old man is reviewed by the medical team during his inpatient hospitalization. He was admitted 72 hours ago after presenting to the emergency department with an acutely painful, erythematous, and swollen right knee accompanied by shaking chills. Initial arthrocentesis yielded turbid synovial fluid containing 85,000 leukocytes/μL85,000 \text{ leukocytes}/\mu L with 92%92\% neutrophils. Following the procedure, he was empirically started on intravenous vancomycin and piperacillin-tazobactam. Today, his temperature has improved to 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}), blood pressure is 128/82 mmHg128/82 \text{ mmHg}, and pulse is 84/min84/\text{min}. The right knee shows decreased swelling and erythema. Blood cultures and synovial fluid cultures obtained on admission are both positive for *Staphylococcus aureus*. Antimicrobial susceptibility testing reveals the following:

AntibioticSusceptibility
PenicillinResistant
OxacillinSusceptible
CefazolinSusceptible
VancomycinSusceptible
Trimethoprim-sulfamethoxazoleSusceptible

Which of the following is the most appropriate next step in antibiotic management?

Show answer & explanation

Answer: Discontinue current antibiotics and initiate intravenous cefazolin

Answer

Discontinue current antibiotics and initiate intravenous cefazolin
The patient has septic arthritis and bacteremia caused by Methicillin-Susceptible *Staphylococcus aureus* (MSSA). The current standard of care and core principle of antibiotic stewardship is to de-escalate broad-spectrum empiric therapy (vancomycin and piperacillin-tazobactam) to a targeted, narrow-spectrum agent once culture sensitivities are available. For invasive MSSA infections, anti-staphylococcal penicillins (e.g., nafcillin, oxacillin) or first-generation cephalosporins (e.g., cefazolin) are the drugs of choice. These beta-lactam agents are rapidly bactericidal and have been conclusively shown to lower mortality, decrease hospital length of stay, and reduce the risk of relapse compared to vancomycin. Therefore, the correct approach is to discontinue both empiric medications and begin intravenous cefazolin.

Step-by-Step Solution

1
Analyze the culture and susceptibility data provided in the vignette.
The pathogen is identified as Staphylococcus aureus that is resistant to penicillin but susceptible to oxacillin, confirming a diagnosis of Methicillin-Susceptible Staphylococcus aureus (MSSA).
Accurate interpretation of sensitivities is required to tailor the empiric antibiotic regimen to definitive therapy.
2
Evaluate the current empiric antibiotic regimen (vancomycin and piperacillin-tazobactam) against standard of care for MSSA.
Both agents are suboptimal for definitive MSSA treatment. Vancomycin has inferior bactericidal activity against MSSA compared to beta-lactams, and piperacillin-tazobactam is unnecessarily broad.
Antibiotic stewardship principles mandate de-escalating to the narrowest-spectrum, most effective agent once a pathogen and its susceptibilities are known.
3
Select the optimal targeted therapy for invasive MSSA infection (septic arthritis and bacteremia).
An intravenous anti-staphylococcal penicillin (e.g., nafcillin, oxacillin) or a first-generation cephalosporin (e.g., cefazolin) is the treatment of choice.
These agents have proven superiority over vancomycin in clearing MSSA bacteremia and improving patient survival, requiring immediate transition to intravenous cefazolin.

Key Concept

Definitive management of Methicillin-Susceptible Staphylococcus aureus (MSSA) bacteremia requires de-escalation to an intravenous narrow-spectrum beta-lactam (such as cefazolin, nafcillin, or oxacillin), which provides superior clinical outcomes compared to vancomycin.
Question 1212Question →

A 6161-year-old male landscape architect presents to the emergency department in coastal Connecticut during early September. His wife reports that he has had 44 days of high-grade fever, drenching sweats, profound fatigue, and progressive confusion. His medical history is significant for a splenectomy at age 2525 following blunt abdominal trauma, and essential hypertension. Vital signs show a temperature of 39.8∘C39.8^\circ\text{C} (103.6∘F103.6^\circ\text{F}), blood pressure of 88/54 mm Hg88/54 \text{ mm Hg}, heart rate of 126/min126/\text{min}, and respiratory rate of 28/min28/\text{min}. Oxygen saturation is 88%88\% on room air. Physical examination reveals marked scleral icterus and pale conjunctivae. Auscultation of the lungs reveals bibasilar crackles.

Laboratory evaluation shows the following:

TestValue
Hemoglobin6.8 g/dL6.8 \text{ g/dL}
Platelet count72,000/mm372,000/\text{mm}^3
Leukocyte count14,200/mm314,200/\text{mm}^3
Total bilirubin5.2 mg/dL5.2 \text{ mg/dL}
Direct bilirubin0.8 mg/dL0.8 \text{ mg/dL}
Lactate dehydrogenase1,350 U/L1,350 \text{ U/L}
Blood urea nitrogen48 mg/dL48 \text{ mg/dL}
Creatinine2.6 mg/dL2.6 \text{ mg/dL}

A peripheral blood smear demonstrates numerous intraerythrocytic pleomorphic ring forms and occasional tetrad structures. Quantitative analysis reveals a parasitemia level of 16%16\%.

Which of the following is the most appropriate management for this patient?

Show answer & explanation

Answer: Intravenous clindamycin, oral quinine, and red blood cell exchange

Answer

Intravenous clindamycin, oral quinine, and red blood cell exchange
The correct management for this patient is intravenous clindamycin, oral quinine, and red blood cell exchange. This patient's presentation of a tick-borne febrile illness in the Northeastern United States, combined with a blood smear showing intraerythrocytic tetrads, confirms the diagnosis of babesiosis. Because he has a history of splenectomy, parasitemia greater than 10%, pulmonary edema, and renal failure, he meets the criteria for severe babesiosis. Severe disease necessitates immediate red blood cell exchange transfusion to rapidly reduce the parasite load and remove inflammatory cytokines and hemolytic byproducts, administered alongside targeted antimicrobial therapy.

Step-by-Step Solution

1
Analyze the clinical presentation and epidemiologic risk factors.
A splenectomized patient in the Northeastern United States presents with fever, jaundice, acute kidney injury, and respiratory distress.
Identifying the geographic and host risk factors helps narrow the differential for acute febrile illnesses.
2
Interpret the laboratory findings and peripheral blood smear.
Labs show severe hemolytic anemia and thrombocytopenia. The blood smear reveals intraerythrocytic tetrads (Maltese cross), which are pathognomonic for Babesia microti.
The blood smear provides the definitive diagnosis, distinguishing it from malaria (which lacks tetrads) and TTP (which has schistocytes).
3
Assess the severity of the infection.
The patient has severe babesiosis, evidenced by a parasitemia level >10%, asplenia, severe anemia (Hb < 8 g/dL), pulmonary edema, and acute kidney injury.
Determining severity is critical because it dictates whether outpatient antimicrobials are sufficient or if invasive interventional management is required.
4
Select the appropriate therapeutic regimen based on disease severity.
Severe babesiosis requires immediate red blood cell exchange transfusion combined with intravenous clindamycin and oral quinine (or IV azithromycin and PO atovaquone).
RBC exchange rapidly decreases the parasite burden and removes toxic byproducts of hemolysis, which is life-saving in severe cases.

Key Concept

Severe babesiosis (indicated by parasitemia >10%, Hb <8 g/dL, pulmonary/renal compromise, or asplenia) requires red blood cell exchange transfusion in addition to targeted antimicrobial therapy.
Estimated Time:2m 0s
Question 1213Question →

A 42-year-old woman is evaluated on the medical floor for ongoing management of a bloodstream infection. She was admitted three days ago with a high fever and localized erythema surrounding a peripheral intravenous catheter site. Blood cultures were drawn, the catheter was removed, and she was started on empiric intravenous vancomycin and intravenous cefepime. The patient is currently afebrile and her localized erythema has resolved. Today, the initial blood cultures are finalized, showing growth of Staphylococcus aureus. Susceptibility testing reveals the organism is resistant to penicillin but susceptible to oxacillin, cefazolin, and vancomycin. Repeat blood cultures drawn 48 hours after admission show no growth. Which of the following is the most appropriate next step in the antibiotic management of this patient?

Show answer & explanation

Answer: Discontinue current antibiotics and initiate intravenous cefazolin

Answer

The most appropriate step is to discontinue the broad-spectrum empiric regimen (vancomycin and cefepime) and initiate targeted therapy with intravenous cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA).
The correct action is to narrow the antibiotic spectrum to intravenous cefazolin. The patient has confirmed methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. For MSSA bloodstream infections, targeted beta-lactam therapy (such as cefazolin, nafcillin, or oxacillin) is the standard of care and is clinically superior to vancomycin, demonstrating faster bacterial clearance and lower mortality rates. Transitioning to targeted therapy also aligns with core antibiotic stewardship principles.

Step-by-Step Solution

1
Interpret the culture and susceptibility results.
The pathogen is Staphylococcus aureus susceptible to oxacillin, confirming it is methicillin-susceptible (MSSA).
Proper identification of the organism and its resistance profile is required to transition from empiric to definitive therapy.
2
Evaluate the current empiric antibiotic regimen.
The patient is on vancomycin (covering MRSA) and cefepime (covering Pseudomonas and other gram-negatives), which is overly broad for isolated MSSA.
Prolonged use of unnecessarily broad antibiotics drives resistance and increases the risk of adverse drug events.
3
Select the optimal definitive therapy for MSSA bacteremia.
Intravenous cefazolin (or an anti-staphylococcal penicillin like nafcillin) is chosen over vancomycin.
Clinical evidence consistently demonstrates that beta-lactams are superior to vancomycin for treating MSSA bacteremia, leading to improved survival and lower clinical failure rates.

Key Concept

Definitive antibiotic management of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia requires de-escalation to an intravenous anti-staphylococcal beta-lactam (e.g., cefazolin or nafcillin), as these agents are superior to vancomycin.
Question 1214Question →

Match each specific autoantibody profile with its most strongly associated clinical presentation or syndrome.

Click a left item, then click its matching right item

Items

Anti-histidyl-tRNA synthetase (Anti-Jo-1) antibodies
Anti-Ro/SSA antibodies
Anti-U1 ribonucleoprotein (RNP) antibodies
Anti-centromere antibodies

Matches

Show answer & explanation

Answer

Anti-Jo-1 matches with antisynthetase syndrome (myopathy, ILD, mechanic's hands). Anti-Ro/SSA matches with neonatal lupus (congenital heart block). Anti-U1 RNP matches with Mixed Connective Tissue Disease (overlap syndrome). Anti-centromere matches with limited cutaneous systemic sclerosis and pulmonary arterial hypertension.
Each specific autoantibody strongly correlates with a distinct clinical syndrome. Anti-Jo-1 identifies patients with antisynthetase syndrome. Anti-Ro/SSA identifies mothers at risk of having infants with neonatal lupus and congenital heart block. Anti-U1 RNP is the defining marker for Mixed Connective Tissue Disease. Anti-centromere antibodies identify patients with limited cutaneous systemic sclerosis who are at high risk for isolated pulmonary arterial hypertension.

Step-by-Step Solution

1
Analyze the first clinical presentation describing myopathy, interstitial lung disease, and hyperkeratotic skin.
Identified as antisynthetase syndrome ('mechanic's hands').
This specific constellation of symptoms is virtually pathognomonic for Anti-Jo-1 (anti-tRNA synthetase) antibody positivity.
2
Evaluate the neonate with heart block and maternal sicca symptoms.
Identified as neonatal lupus due to maternal Sjögren syndrome.
Maternal Anti-Ro/SSA antibodies cross the placenta and damage the fetal AV node, leading to complete heart block.
3
Review the systemic autoimmune disease with overlapping features of three connective tissue diseases.
Identified as Mixed Connective Tissue Disease (MCTD).
MCTD is strictly defined by this clinical overlap in the presence of Anti-U1 RNP antibodies.
4
Assess the final presentation involving limited cutaneous systemic sclerosis and pulmonary arterial hypertension risk.
Matched to Anti-centromere antibodies.
Anti-centromere antibodies are the primary serologic marker for limited cutaneous systemic sclerosis and strongly correlate with the development of PAH without significant interstitial lung disease.

Key Concept

Autoantibody profiles serve as critical diagnostic and prognostic markers for distinct rheumatologic syndromes, guiding both diagnosis and the screening for specific severe organ manifestations.
Question 1215Question →

A 6262-year-old man is hospitalized on the general medical ward for a severe exacerbation of chronic obstructive pulmonary disease and suspected superimposed pneumonia. He is prescribed a new regimen of intravenous piperacillin-tazobactam. 1010 minutes into the first infusion, the rapid response team is called because the patient suddenly develops diffuse urticaria, facial swelling, a high-pitched inspiratory noise, and profound shortness of breath. His vital signs reveal a blood pressure of 80/4580/45 mm Hg, a heart rate of 128128/min, and an oxygen saturation of 88%88\% on room air. Arrange the following acute management steps in the most appropriate chronological sequence according to established life-support guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first halt the offending infusion, immediately administer intramuscular epinephrine, optimize hemodynamics with positioning and intravenous fluids, administer adjunctive antihistamines and steroids, and finally obtain a serum tryptase level once the patient is stabilized.
In the management of anaphylaxis, the offending agent must first be removed. Intramuscular epinephrine is the definitive first-line therapy because its alpha-1 and beta-2 agonist properties immediately reverse peripheral vasodilation and bronchoconstriction. Hemodynamic support with supine positioning and intravenous fluids is the next critical step to manage distributive shock. Antihistamines and glucocorticoids are second-line, adjunctive therapies that provide delayed symptomatic relief and may prevent biphasic reactions; they must never delay epinephrine administration. Finally, drawing a serum tryptase level is a diagnostic step performed after acute stabilization.

Step-by-Step Solution

1
Recognize the clinical presentation of anaphylactic shock.
The patient's sudden urticaria, angioedema, stridor, and hypotension shortly after starting a beta-lactam antibiotic confirm IgE-mediated anaphylaxis.
Accurate recognition is critical to immediately initiate the life-saving anaphylaxis protocol rather than mistakenly treating for an isolated COPD exacerbation.
2
Prioritize interventions based on immediate life-saving potential.
Stopping the trigger and administering epinephrine are identified as the paramount first steps.
Epinephrine is the only medication that rapidly reverses the life-threatening cardiovascular and airway complications of anaphylaxis.
3
Sequence hemodynamic support and adjunctive therapies.
Fluids and positioning are sequenced before antihistamines and steroids.
Fluids combat the acute distributive shock. Antihistamines and steroids have no immediate effect on shock or airway obstruction and must never delay epinephrine or fluid resuscitation.
4
Determine the timing for diagnostic laboratory testing.
Serum tryptase is ordered as the final step.
Diagnostic testing should only occur after the patient is clinically stable. Furthermore, tryptase levels peak 11 to 22 hours post-event, making immediate measurement less useful.

Key Concept

The management of anaphylaxis follows a strict hierarchy: immediate cessation of the trigger, prompt intramuscular epinephrine, supportive hemodynamic resuscitation (fluids and positioning), followed by delayed-onset adjunctive pharmacotherapy (antihistamines and steroids), and subsequent diagnostic testing.
Question 1216Question →

A 52-year-old man is recovering on the surgical ward following an extensive bowel resection for ischemic colitis. On postoperative day 2, his hemoglobin is found to be 6.5 g/dL, and a transfusion of packed red blood cells is initiated. Approximately 25 minutes after the transfusion begins, the patient suddenly develops severe chills, a temperature of 39.2°C (102.6°F), and worsening right flank pain. His blood pressure drops to 90/60 mm Hg, and his heart rate increases to 118/min. A Foley catheter placed in the operating room now drains dark, reddish-brown urine. Which of the following is the most appropriate initial step in management?

Show answer & explanation

Answer: Stop the transfusion and begin vigorous intravenous hydration with normal saline

Answer

The most appropriate initial step is to immediately stop the transfusion and initiate vigorous intravenous hydration with normal saline.
The patient's presentation of fever, chills, flank pain, hypotension, and dark urine (hemoglobinuria) occurring within minutes of starting a packed red blood cell transfusion is the classic presentation of an acute hemolytic transfusion reaction (AHTR). AHTR is a medical emergency usually caused by ABO incompatibility resulting from a clerical error. The very first and most crucial step in management is to stop the transfusion immediately to limit the amount of incompatible blood entering the patient's circulation. Following this, the administration of vigorous intravenous normal saline is critical to maintain urine output and prevent acute tubular necrosis from the toxic effects of free hemoglobin on the kidneys.

Step-by-Step Solution

1
Recognize the clinical presentation of an acute hemolytic transfusion reaction (AHTR).
The combination of rapid-onset fever, flank pain, hypotension, and hemoglobinuria shortly after starting a blood transfusion confirms suspected AHTR, typically due to ABO incompatibility.
Identifying the etiology of sudden clinical deterioration during a transfusion dictates the immediate response.
2
Determine the most critical immediate intervention for AHTR.
The transfusion must be stopped immediately, and intravenous fluids must be administered.
Stopping the transfusion prevents further administration of incompatible blood, while aggressive normal saline hydration minimizes the risk of acute kidney injury from hemoglobin-induced tubular necrosis.

Key Concept

The initial management of an acute hemolytic transfusion reaction requires immediately stopping the transfusion and providing aggressive intravenous fluid resuscitation to prevent acute kidney injury.
Question 1217Question →

A 62-year-old man is evaluated in the intensive care unit for antimicrobial management. He was admitted 8 days ago after a severe motor vehicle collision resulting in multiple rib fractures and a pulmonary contusion. He has required mechanical ventilation since admission. On hospital day 6, he developed a new fever, increased purulent endotracheal secretions, and a right lower lobe consolidation on chest radiography. He was empirically started on intravenous vancomycin and piperacillin-tazobactam for suspected ventilator-associated pneumonia.

Today (hospital day 8), his temperature is 37.6°C (99.7°F), blood pressure is 122/78 mmHg, and heart rate is 84/min. Endotracheal aspirate cultures obtained on day 6 now show >105>10^5 CFU/mL of *Enterobacter cloacae*. Blood cultures remain sterile. Antimicrobial susceptibility testing for the *E. cloacae* isolate is reported below:

AntibioticResult
AmpicillinResistant
CefazolinResistant
CeftriaxoneSusceptible
CefepimeSusceptible
Piperacillin-tazobactamSusceptible
MeropenemSusceptible
TobramycinSusceptible

Which of the following is the most appropriate modification to this patient's pharmacotherapy?

Show answer & explanation

Answer: Discontinue piperacillin-tazobactam and vancomycin, and initiate intravenous cefepime

Answer

The most appropriate step is to discontinue piperacillin-tazobactam and vancomycin, and initiate intravenous cefepime.
The patient has ventilator-associated pneumonia (VAP) caused by *Enterobacter cloacae*. This organism is notorious for harboring an inducible, chromosomal *AmpC* beta-lactamase gene. A critical tenet of infectious disease management is recognizing that organisms with moderate-to-high risk of AmpC production (such as *Enterobacter*, *Citrobacter freundii*, and *Klebsiella aerogenes*) should not be treated with third-generation cephalosporins (e.g., ceftriaxone) or beta-lactam/beta-lactamase inhibitor combinations (e.g., piperacillin-tazobactam) for invasive infections. Even when these drugs are reported as 'susceptible' by the microbiology laboratory, exposing the organism to them selects for derepressed mutants that hyperproduce the AmpC enzyme, rapidly destroying the antibiotic and causing clinical failure.

The drugs of choice for invasive AmpC-producing infections are cefepime and carbapenems (e.g., meropenem), as they are relatively stable against AmpC hydrolysis. To practice appropriate antimicrobial stewardship and preserve carbapenems for highly resistant organisms, cefepime is the preferred step-down agent. Additionally, vancomycin must be discontinued because the culture did not grow methicillin-resistant *Staphylococcus aureus* (MRSA).

Step-by-Step Solution

1
Analyze the culture data and clinical scenario.
The patient has ventilator-associated pneumonia caused by Enterobacter cloacae. Blood cultures are negative, and there is no MRSA isolated.
Establishing the definitive pathogen determines the required spectrum of antimicrobial coverage.
2
Evaluate the need for continued empiric therapy.
Vancomycin can be safely discontinued.
Since respiratory cultures did not grow MRSA, continuing vancomycin violates antibiotic stewardship principles.
3
Select the appropriate definitive beta-lactam agent based on the organism's intrinsic resistance mechanisms.
Cefepime is selected over ceftriaxone or piperacillin-tazobactam.
Enterobacter cloacae possesses an inducible AmpC beta-lactamase gene. Treating invasive infections with ceftriaxone or piperacillin-tazobactam can induce enzyme production leading to clinical failure, despite apparent in vitro susceptibility.

Key Concept

Invasive infections caused by organisms with a moderate-to-high risk of inducible AmpC production (e.g., Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii) should be treated with cefepime or a carbapenem, avoiding third-generation cephalosporins and piperacillin-tazobactam even if they appear susceptible in vitro.
Question 1218Question →

A 6262-year-old woman is evaluated in the clinic for bilateral knee pain that has progressively worsened over the past 22 years. The pain is exacerbated by walking and relieved by rest. She reports no morning stiffness. Her body mass index is 33 kg/m233 \text{ kg/m}^2. Physical examination reveals bony enlargement and crepitus in both knees without significant warmth or erythema. Radiographs demonstrate asymmetric joint space narrowing and osteophyte formation. Arrange the following therapeutic interventions in the most appropriate stepwise sequence for managing this patient's condition, progressing from initial first-line management to definitive end-stage therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The most appropriate sequence is weight loss and physical therapy, followed by topical NSAIDs, oral NSAIDs, intra-articular glucocorticoid injections, and finally total knee arthroplasty.
The correct sequence follows the standard guidelines for osteoarthritis management, emphasizing a progressive approach. The foundation of treatment relies on nonpharmacologic lifestyle modifications. Pharmacologic management then steps up from localized, low-risk therapies to systemic medications, balancing efficacy with potential side effects. Invasive treatments like injections and eventually surgery are reserved for refractory or end-stage disease.

Step-by-Step Solution

1
Establish the diagnosis based on the clinical presentation
Knee osteoarthritis
The patient's chronic exertional joint pain, absence of morning stiffness, obesity, and characteristic radiographic findings confirm the diagnosis.
2
Identify the foundational first-line therapy
Weight loss and physical therapy
Nonpharmacologic modalities are the safest and most critical initial interventions for all patients with osteoarthritis to reduce joint loading.
3
Determine initial pharmacotherapy
Topical NSAIDs
Topical agents provide localized relief with minimal systemic absorption, making them the preferred first-line pharmacological option prior to oral medications.
4
Determine subsequent pharmacotherapy escalation
Oral NSAIDs, followed by intra-articular injections
Systemic and invasive therapies are sequentially added when more conservative localized measures fail to provide adequate pain relief or functional improvement.
5
Identify definitive end-stage therapy
Total knee arthroplasty
Surgical joint replacement is reserved for end-stage, intractable pain and functional decline despite maximal medical therapy.

Key Concept

Stepwise escalation of therapy in knee osteoarthritis, prioritizing least invasive and lowest toxicity interventions.
Question 1219Question →

Match each clinical presentation of an immunocompromised patient with advanced HIV infection to the most appropriate initial targeted pharmacologic therapy.

Click a left item, then click its matching right item

Items

A 3434-year-old man presents with new-onset floaters, photophobia, and decreased visual acuity. Fundoscopy reveals yellow-white retinal exudates with adjacent areas of hemorrhage along the vascular arcades.
A 4242-year-old woman presents with a subacute onset of severe headache, low-grade fever, and malaise. Lumbar puncture reveals elevated opening pressure, lymphocytic pleocytosis, and encapsulated yeast cells on an India ink stain.
A 2929-year-old man presents with new-onset focal seizures and right-sided hemiparesis. MRI of the brain demonstrates multiple ring-enhancing lesions with surrounding edema, predominantly located in the basal ganglia.
A 3838-year-old man presents with a 33-week history of progressive dyspnea on exertion and a dry, nonproductive cough. Chest radiograph shows diffuse, bilateral interstitial infiltrates, and arterial blood gas reveals a PaO2PaO_2 of 6565 mm Hg.

Matches

Show answer & explanation

Answer

The correct matches pair the CMV retinitis presentation with valganciclovir/ganciclovir; the Cryptococcal meningitis presentation with liposomal amphotericin B and flucytosine; the Toxoplasma encephalitis presentation with sulfadiazine, pyrimethamine, and leucovorin; and the severe Pneumocystis pneumonia presentation with trimethoprim-sulfamethoxazole and corticosteroids.
Each vignette describes a classic presentation of a major HIV-associated opportunistic infection that requires a specific first-line antimicrobial regimen. CMV retinitis is treated with valganciclovir. Cryptococcal meningitis induction requires amphotericin B and flucytosine. Toxoplasmosis is treated with sulfadiazine, pyrimethamine, and leucovorin. Severe PCP requires trimethoprim-sulfamethoxazole combined with corticosteroids to mitigate fatal inflammatory lung injury.

Step-by-Step Solution

1
Analyze the first clinical vignette regarding the retinal findings.
Identified Cytomegalovirus (CMV) retinitis based on the description of exudates and hemorrhages.
Recognizing the specific pathogen allows for matching with its targeted antiviral therapy, valganciclovir.
2
Examine the second clinical vignette focusing on the cerebrospinal fluid (CSF) analysis.
Identified Cryptococcal meningitis based on encapsulated yeast cells visualized via India ink stain.
Determines the need for aggressive induction antifungal therapy with amphotericin B and flucytosine rather than monotherapy.
3
Evaluate the third clinical vignette involving neuroimaging findings.
Identified Toxoplasma encephalitis based on multiple ring-enhancing lesions in the basal ganglia.
Guides the selection of targeted anti-parasitic therapy with sulfadiazine and pyrimethamine.
4
Assess the fourth clinical vignette noting the respiratory symptoms and blood gas results.
Identified severe Pneumocystis jirovecii pneumonia (PCP) due to the characteristic infiltrates and a PaO2PaO_2 of 6565 mm Hg.
A PaO2<70PaO_2 < 70 mm Hg is a strict indication to add systemic corticosteroids to the primary antimicrobial therapy (trimethoprim-sulfamethoxazole) to reduce mortality.

Key Concept

Diagnosis and initial targeted pharmacotherapy for major opportunistic infections in patients with advanced HIV/AIDS.
Question 1220Question →

A 6868-year-old woman is brought to the emergency department by her family due to a 2424-hour history of severe generalized headache, high fever, and progressive confusion. Her temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 110/70 mmHg110/70 \text{ mmHg}, pulse is 115/min115/\text{min}, and respirations are 18/min18/\text{min}. On physical examination, the patient is lethargic and oriented only to her name. She exhibits nuchal rigidity. There are no focal neurologic deficits, and funduscopic examination reveals no papilledema. Which of the following represents the most appropriate sequence of steps in the management of this patient?

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management is: First, obtain blood cultures; second, administer empiric intravenous antibiotics and dexamethasone; third, perform a noncontrast CT scan of the head; and finally, perform a lumbar puncture.
The standard of care for suspected bacterial meningitis is typically to obtain blood cultures, perform a lumbar puncture, and then start antibiotics. However, this patient has distinct indications for a CT scan of the head prior to a lumbar puncture (specifically, age greater than 60 and altered mental status). In this scenario, blood cultures must be drawn immediately to preserve the ability to identify the pathogen. Immediately afterward, empiric antibiotics (e.g., ceftriaxone, vancomycin, ampicillin) and dexamethasone must be administered. Antibiotics should never be delayed for the CT scan or lumbar puncture, as delays drastically increase mortality. Once medical therapy is initiated, the CT scan is performed to rule out any mass effect, followed finally by the lumbar puncture if the imaging is clear.

Step-by-Step Solution

1
Evaluate the clinical presentation and identify the suspected diagnosis.
The patient's fever, headache, nuchal rigidity, and altered mental status strongly suggest bacterial meningitis.
Recognizing the life-threatening nature of bacterial meningitis dictates the urgency of subsequent interventions.
2
Assess for indications requiring neuroimaging prior to cerebrospinal fluid analysis.
The patient's age (greater than 60) and altered mental status (lethargic, confused) mandate a CT scan before a lumbar puncture.
Performing a lumbar puncture in the presence of elevated intracranial pressure or a mass lesion can precipitate fatal cerebral herniation.
3
Determine the appropriate sequencing of diagnostic and therapeutic interventions.
Blood cultures are drawn immediately, followed by the administration of empiric antibiotics and dexamethasone, before sending the patient for a CT scan. The lumbar puncture is performed last.
Antibiotic administration must not be delayed by the need for a CT scan or lumbar puncture, as delays significantly increase mortality. However, blood cultures must be drawn before antibiotics to ensure pathogen recovery.

Key Concept

Management sequence for suspected bacterial meningitis with indications for head imaging
PreviousPage 61 / 158Next